Antibodies recognizing tau
US11926659B2 · kind B2 · utility
0Cited by
65References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2021 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Jan 19, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.